Gicquel C - Search Results

1

Gicquel C, Baudin E, Lebouc Y, Schlumberger M. Gicquel C, et al. Ann Oncol. 1997 May;8(5):423-7. doi: 10.1023/a:1008257530919. Ann Oncol. 1997. PMID: 9233519 Free article. Review. No abstract available.

2

Recent advances in the pathogenesis of adrenocortical tumours.

Gicquel C, Bertagna X, Le Bouc Y. Gicquel C, et al. Eur J Endocrinol. 1995 Aug;133(2):133-44. doi: 10.1530/eje.0.1330133. Eur J Endocrinol. 1995. PMID: 7655635 Review. No abstract available.

3

Oncogenic mutations of alpha-Gi2 protein are not determinant for human adrenocortical tumourigenesis.

Gicquel C, Dib A, Bertagna X, Amselem S, Le Bouc Y. Gicquel C, et al. Eur J Endocrinol. 1995 Aug;133(2):166-72. doi: 10.1530/eje.0.1330166. Eur J Endocrinol. 1995. PMID: 7655640

4

[Insulin-like growth factor II (IGF II) and adrenocortical tumorigenesis].

Gicquel C, Le Bouc Y. Gicquel C, et al. Ann Endocrinol (Paris). 1995;56(6):617-8. Ann Endocrinol (Paris). 1995. PMID: 8787355 French. No abstract available.

5

Molecular markers for malignancy in adrenocortical tumors.

Gicquel C, Le Bouc Y. Gicquel C, et al. Horm Res. 1997;47(4-6):269-72. doi: 10.1159/000185475. Horm Res. 1997. PMID: 9167963

6

Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors.

Gicquel C, Raffin-Sanson ML, Gaston V, Bertagna X, Plouin PF, Schlumberger M, Louvel A, Luton JP, Le Bouc Y. Gicquel C, et al. J Clin Endocrinol Metab. 1997 Aug;82(8):2559-65. doi: 10.1210/jcem.82.8.4170. J Clin Endocrinol Metab. 1997. PMID: 9253334

7

Increased levels of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 are associated with malignancy in sporadic adrenocortical tumors.

Boulle N, Logié A, Gicquel C, Perin L, Le Bouc Y. Boulle N, et al. Among authors: gicquel c. J Clin Endocrinol Metab. 1998 May;83(5):1713-20. doi: 10.1210/jcem.83.5.4816. J Clin Endocrinol Metab. 1998. PMID: 9589681

8

Autocrine role of IGF-II in proliferation of human adrenocortical carcinoma NCI H295R cell line.

Logié A, Boulle N, Gaston V, Perin L, Boudou P, Le Bouc Y, Gicquel C. Logié A, et al. Among authors: gicquel c. J Mol Endocrinol. 1999 Aug;23(1):23-32. doi: 10.1677/jme.0.0230023. J Mol Endocrinol. 1999. PMID: 10425444

9

Pathogenesis of adrenocortical incidentalomas and genetic syndromes associated with adrenocortical neoplasms.

Gicquel C, Bertherat J, Le Bouc Y, Bertagna X. Gicquel C, et al. Endocrinol Metab Clin North Am. 2000 Mar;29(1):1-13, vii. doi: 10.1016/s0889-8529(05)70112-2. Endocrinol Metab Clin North Am. 2000. PMID: 10732260 Review.

10

Establishment and characterization of a human adrenocortical carcinoma xenograft model.

Logié A, Boudou P, Boccon-Gibod L, Baudin E, Vassal G, Schlumberger M, Le Bouc Y, Gicquel C. Logié A, et al. Among authors: gicquel c. Endocrinology. 2000 Sep;141(9):3165-71. doi: 10.1210/endo.141.9.7668. Endocrinology. 2000. PMID: 10965887

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters